Immunotherapy

Immunotherapy through the skin might have applications beyond food allergies, with research getting underway for treatment of Crohn's disease.  

WHO and UNICEF appreciate the commitment by the United States Government to stop making operational use of immunization campaigns.  

Source: http://biotechstrategyblog.com/2015/04/reflections-on-aacr-2015-cancer-immunotherapy-data.html/  

Progress towards global vaccination targets for 2015 is far off track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases. In the lead-up to World Immunization Week 2015 (24 -30 April), the WHO is calling for renewed efforts to get progress back on course.  

Dr. Gerald Lee is an Assistant Professor on faculty at the University of Louisville. He is the Division Chief of both the adult and pediatrics department of ...  

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of...  

A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly...  

A drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton.  

Inovio Pharmaceuticals, Inc. has announced preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck...  

Giving the two immunotherapies ipilimumab and nivolumab simultaneously yielded better treatment responses than ipilimumab alone in patients with advanced melanoma who received no prior...  

Immunotherapy with natural signaling substance relieves skin conditionA three-character code brings relief to patients with psoriasis and sheds light on complex...  

The idea of fighting cancer with immunotherapy is to trigger the immune system. Now, a new study suggests recruiting both the innate and the adaptive immune system works best.  

Spreading the success of cancer immunotherapy beyond those patients currently enjoying powerful, long-term responses to treatment requires greater understanding of the immune response to tumors...  

Cancer immunotherapy can successfully use the body's own immune system to kill tumor cells.  

Results of a new study by UCLA researchers has found that a new triple combination drug therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK...  

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer...